**Core Concept:**
Cough variant asthma is a subtype of asthma characterized by recurrent, persistent coughing without typical asthma symptoms like wheezing, chest tightness, or shortness of breath. It is believed to be caused by airway hyperresponsiveness and inflammation, similar to classic asthma. The cough variant often presents in adults and can be mistaken for a chronic cough of other origin.

**Why the Correct Answer is Right:**
The correct answer is administering bronchodilators (e.g., short-acting beta-agonists) and corticosteroids (e.g., inhaled or oral) as these medications are effective in controlling airway hyperresponsiveness and inflammation in asthma patients. Bronchodilators help relax smooth muscle in airways, reducing airway narrowing, and corticosteroids reduce inflammation and prevent the release of inflammatory mediators, reducing airway hyperresponsiveness.

**Why Each Wrong Option is Incorrect:**
A. Anticholinergics (e.g., ipratropium) are not the first-line treatment for cough variant asthma as they primarily act on the parasympathetic nervous system and are more effective in treating bronchoconstriction due to cholinergic stimuli.
B. Antihistamines (e.g., cetirizine) are not recommended for cough variant asthma since they primarily affect histamine-mediated allergic reactions, not asthma-related inflammation and airway hyperresponsiveness.
C. Tranquilizers (e.g., alprazolam) are not prescribed for cough variant asthma as they are used to treat anxiety disorders and are not targeted to the airway inflammation and hyperresponsiveness in cough variant asthma.
D. Leukotriene receptor antagonists (e.g., montelukast) are not first-line treatment for cough variant asthma as they primarily target leukotriene-mediated inflammation, which is not the primary cause of cough variant asthma.

**Clinical Pearl:**
In cough variant asthma, the misdiagnosis of asthma can lead to inappropriate therapy with anticholinergics, antihistamines, or tranquilizers. The correct approach is to initiate bronchodilators and corticosteroids, which target airway inflammation and hyperresponsiveness, thus improving the symptoms and reducing the frequency and severity of coughing episodes.

**Correct Answer:** D. Leukotriene receptor antagonists (e.g., montelukast) are not first-line treatment for cough variant asthma as they primarily target leukotriene-mediated inflammation, which is not the primary cause of cough variant asthma.

**Why the Correct Answer is Right:**
Leukotriene receptor antagonists (LTRAs) are a class of medications that block the action of leukotrienes, which are potent inflammatory mediators involved in asthma exacerbations. While LTRAs can be effective in treating cough variant asthma, they are not as effective as bronchodilators (beta2-agonists) and corticosteroids in controlling airway inflammation and hyperresponsiveness, which are the primary hallmarks of cough variant asthma.